Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

Top 5 Semiconductor Stocks to Watch Today (November 14, 2025): Nvidia, Micron, Broadcom, TSMC and Applied Materials

Top 5 Semiconductor Stocks to Watch Today (November 14, 2025): Nvidia, Micron, Broadcom, TSMC and Applied Materials

Semiconductor stocks are back in the spotlight today, November 14, 2025, as a sharp tech-led sell-off collides with ongoing excitement around artificial intelligence (AI), data centers and high‑performance chips. Global markets are under pressure after Federal Reserve officials signaled a
Virgin Galactic Rockets 15% on Space Tourism Buzz – Can SPCE Defy Gravity or Crash Back to Earth?

Virgin Galactic (SPCE) Narrows Q3 Loss, Reaffirms Late‑2026 Spaceflight Launch as Stock Rebounds

Virgin Galactic Holdings, Inc. (NYSE: SPCE) is back in the headlines on Friday, November 14, 2025, after releasing third‑quarter 2025 results and reaffirming its long‑awaited commercial spaceflight timeline, even as the business remains deeply loss‑making and pre‑revenue.  Stock Titan+1 Today’s
Social Security Surprise: No SSI Check on Nov. 1 – See Why Your Payment Arrives Early

IRS Direct Deposit Stimulus Check in November 2025? Fact Check on $1,390, $2,000 Relief Payments, DOGE Checks and Trump’s Tariff Dividend

Updated: November 14, 2025 Searches for “IRS stimulus check,” “IRS direct deposit relief payment,” and “stimulus payment November 2025” have exploded again — helped along by viral posts promising $1,390, $1,702, or even $2,000 hitting bank accounts via direct deposit
14 November 2025
Pfizer Stock Surges 15% on Trump’s Pricing Pact & $7.3B Obesity Deal – Can the Rally Last?

Pfizer Stock (PFE) Before the Bell on November 14, 2025: Metsera Deal Closes, BioNTech Stake Cut and Guidance Raised

As Wall Street heads into Friday’s session, Pfizer stock is trading slightly lower in premarket action while investors digest a trio of big developments: the completed acquisition of obesity‑drug developer Metsera, a sharp reduction in Pfizer’s stake in BioNTech, and
1 80 81 82 83 84 424
Go toTop